Olympus Co. (OTCMKTS:OLYMY) Short Interest Down 99.9% in June

Olympus Co. (OTCMKTS:OLYMY) was the recipient of a large decrease in short interest during the month of June. As of June 30th, there was short interest totaling 13 shares, a decrease of 99.9% from the June 15th total of 11,090 shares. Based on an average daily volume of 160,531 shares, the days-to-cover ratio is presently 0.0 days.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group lowered shares of Olympus from a “buy” rating to a “neutral” rating in a research report on Monday, June 15th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, Olympus has a consensus rating of “Hold”.

Olympus Trading Up 1.2%

Olympus stock traded up $0.13 on Friday, hitting $10.87. The company’s stock had a trading volume of 31,621 shares, compared to its average volume of 108,660. The company has a fifty day moving average price of $10.82 and a 200-day moving average price of $10.76. Olympus has a one year low of $8.08 and a one year high of $13.73.

About Olympus

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.